Tami Katz

508 total citations
11 papers, 216 citations indexed

About

Tami Katz is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Tami Katz has authored 11 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Genetics and 5 papers in Immunology. Recurrent topics in Tami Katz's work include Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Tami Katz is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Tami Katz collaborates with scholars based in Israel. Tami Katz's co-authors include Irit Avivi, Ilan Beer, Michal Bassani‐Sternberg, Arie Admon, Eilon Barnea, Anat Aharon, Benjamin Brenner, Jacob M. Rowe, Judith Radnay and Hava Shapiro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and British Journal of Haematology.

In The Last Decade

Tami Katz

10 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tami Katz Israel	7	119	89	71	49	29	11	216
W.R. Gerritsen United States	9	116 1.0×	107 1.2×	125 1.8×	144 2.9×	27 0.9×	20	369
Baptiste Louveau France	9	78 0.7×	67 0.8×	74 1.0×	19 0.4×	17 0.6×	36	225
Juan Carlos Balandrán Mexico	10	113 0.9×	89 1.0×	68 1.0×	95 1.9×	27 0.9×	19	282
Can Hekim Finland	9	117 1.0×	61 0.7×	105 1.5×	55 1.1×	86 3.0×	14	271
Anne Murray United States	4	103 0.9×	112 1.3×	67 0.9×	18 0.4×	10 0.3×	8	230
Kaya Zhu United States	7	276 2.3×	52 0.6×	94 1.3×	40 0.8×	30 1.0×	8	381
Risa Miyashita Japan	7	124 1.0×	194 2.2×	66 0.9×	22 0.4×	13 0.4×	7	351
Rika Kato Japan	7	63 0.5×	114 1.3×	43 0.6×	15 0.3×	12 0.4×	10	206
Hayaatun Is’harc United Kingdom	5	108 0.9×	162 1.8×	243 3.4×	20 0.4×	29 1.0×	5	325
Emily Labriola–Tompkins United States	6	146 1.2×	118 1.3×	59 0.8×	45 0.9×	13 0.4×	10	277

Countries citing papers authored by Tami Katz

Since Specialization

Citations

This map shows the geographic impact of Tami Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tami Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tami Katz more than expected).

Fields of papers citing papers by Tami Katz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tami Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tami Katz. The network helps show where Tami Katz may publish in the future.

Co-authorship network of co-authors of Tami Katz

This figure shows the co-authorship network connecting the top 25 collaborators of Tami Katz. A scholar is included among the top collaborators of Tami Katz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tami Katz. Tami Katz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Horowitz, Netanel A., et al.. (2022). In chronic lymphocytic leukemia, activation of the thrombopoietin receptor promotes T‐cell inhibitory properties, contributing to immunosuppression. European Journal Of Haematology. 110(4). 371–378.

Avivi, Irit, et al.. (2018). Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation. Cancer Immunology Immunotherapy. 67(5). 739–748. 8 indexed citations

Avivi, Irit, et al.. (2018). Extracellular vesicles of multiple myeloma cells utilize the proteasome inhibitor mechanism to moderate endothelial angiogenesis. Angiogenesis. 22(1). 185–196. 49 indexed citations

Benyamini, Noam, Irit Avivi, Eldad J. Dann, et al.. (2016). Comparison of engraftment following different stem cell mobilization modalities in patients with multiple myeloma treated with a uniform induction regimen containing bortezomib, cyclophosphamide and dexamethasone. Annals of Hematology. 96(3). 461–467. 6 indexed citations

Benyamini, Noam, et al.. (2016). The Effect of Lenalidomide on Multiple Myeloma Associated Macrophages. Blood. 128(22). 3689–3689. 1 indexed citations

Horowitz, Netanel A., et al.. (2016). TLR9-Regulated IL10 Mediates Immune Inhibitory Activity of Chronic Lymphocytic Leukemia B-Cells. Blood. 128(22). 4377–4377. 1 indexed citations

Avivi, Irit, et al.. (2014). Chronic Lymphocytic Leukemia Cells Acquire a Regulatory B-Cell Phenotype Modified By PD1 Signaling. Blood. 124(21). 3319–3319. 1 indexed citations

Bassani‐Sternberg, Michal, Eilon Barnea, Ilan Beer, et al.. (2010). Soluble plasma HLA peptidome as a potential source for cancer biomarkers. Proceedings of the National Academy of Sciences. 107(44). 18769–18776. 103 indexed citations

Elhasid, Ronit, Ronit Leiba, Sergey Postovsky, et al.. (2007). Safe and Efficacious Allogeneic Bone Marrow Transplantation for Nonmalignant Disorders Using Partial T Cell Depletion and No Posttransplantation Graft-Versus-Host-Disease Prophylaxis. Biology of Blood and Marrow Transplantation. 13(3). 329–338. 13 indexed citations

10.

Kassis, Imad, Ilana Oren, Renato Finkelstein, et al.. (2007). Contamination of Peripheral Hematopoeitic Stem Cell Products With aMycobacterium mucogenicum–Related Pathogen. Infection Control and Hospital Epidemiology. 28(6). 755–757. 8 indexed citations

11.

Szyper‐Kravitz, Martine, Orit Uziel, Hava Shapiro, et al.. (2003). Granulocyte colony‐stimulating factor administration upregulates telomerase activity in CD34⁺ haematopoietic cells and may prevent telomere attrition after chemotherapy. British Journal of Haematology. 120(2). 329–336. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact